Howard, F. M., Babu, R., Dolezal, J. M., Huo, D., Borowsky, A. D., Symmans, W. F. F., Campbell, M. J., Wolf, D. M., Hirst, G. L., Venters, S., Asare, A., Kanaparthi, S., Blenman, K., Shan, N. L., Perou, C. M., Esserman, L., Veer, L. V. T., Pusztai, L., Nanda, R., Pearson, A. T. (2025). Gene expression signatures (GES) derived from digital histology to predict pathologic complete response (pCR) to neoadjuvant chemotherapy (CT) in ISPY2 and other trial/real world cohorts.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.587